Trial intelligence / Profile preview

Low-dose aspirin for prevention of IVF cycle complications in women with polycystic ovarian syndrome

IRCT201105216541N1Phase 2Completed

Sponsor
Shiraz University of Medical Sciences
Start
May 2011
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of aspirin in polycystic ovary syndrome (PCOS), sponsored by Shiraz University of Medical Sciences. Started May 2011; status: completed.

02

Drugs

aspirin
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on IRCT201105216541N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201105216541N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call